SUNEETA KUMARI: Open Payments
NPI 1730701699 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$432 in 20 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $109 · 2025 $432
Food & beverage: $427Education: $5
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 6 | $159 |
| E.R. Squibb & Sons, L.L.C. | 4 | $79 |
| Otsuka America Pharmaceutical, Inc. | 3 | $74 |
| Teva Pharmaceuticals USA, Inc. | 4 | $66 |
| Neurocrine BioSciences, Inc. | 1 | $21 |
| ABBVIE INC. | 1 | $19 |
| Lundbeck LLC | 1 | $15 |
Products named: INVEGA SUSTENNA, COBENFY, UZEDY, ABILIFY MAINTENA, ABILIFY ASIMTUFII, INGREZZA, VRAYLAR.
Industry payments across MD — which companies pay providers there.
